The producer of hydroxychloroquine sulfate tablets announced it will donate 6 million tablets by March 31st and more than 10 million within a month.

Announced on March 20, 2020, by Israel-based Teva Pharmaceutical Industries Ltd., these hydroxychloroquine sulfate tablets will be distributed through medication wholesalers to hospitals across the USA.

This donation is intended to meet the urgent demand for this medicine as an investigational target to treat patients suffering from COVID-19 disease.

Although the product is not currently approved for use in the treatment of COVID-19, it is currently under investigation for efficacy against the coronavirus and has been requested by US government officials to be made available for use immediately.

Hydroxychloroquine sulfate tablets manufactured by Teva are approved by the U.S. Food and Drug Administration for the treatment of diseases such as malaria, lupus erythematosus, and rheumatoid arthritis.

“We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” said Brendan O’Grady, Teva Executive Vice President, North America Commercial.

The Company is also reviewing the supply of both hydroxychloroquine and chloroquine globally to determine whether there are additional supply and access opportunities for patients.

The FDA Commissioner, Stephen M. Hahn, M.D., said on March 19, 2020, “We understand and recognize the urgency with which we are all seeking prevention and treatment options for COVID-19.”

“We also must ensure these products are effective; otherwise we risk treating patients with a product that might not work when they could have pursued other, more appropriate, treatments.”

“We will take all steps to ensure chloroquine remains available for patients who take it to treat severe and life-threatening illnesses such as lupus,” concluded Dr. Hahn.

Teva Pharmaceutical has been developing and producing medicines to improve people’s lives for more than a century.

SARS-CoV-2 outbreak news is published by Coronavirus Today.

COVID-19 therapeutic medication news published by Precision Vaccinations.